AMPH FY 2014 Earnings — Amphastar Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena

AMPHAmphastar Pharmaceuticals, Inc.

$863M

FY 2014 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$210M-8.4% YoY

Gross Profit

$51M24.4% margin

Operating Income

-$18M-8.5% margin

Net Income

-$11M-5.1% margin

EPS (Diluted)

$-0.25

Cash Flow

Operating Cash Flow

$21M

Free Cash Flow

$553,000

Stock-Based Comp.

$9M

Balance Sheet

Total Assets

$389M

Total Liabilities

$108M

Stockholders' Equity

$282M

Cash & Equivalents

$68M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$210M	$230M	-8.4%
Gross Profit	$51M	$87M	-41.1%
Operating Income	-$18M	$17M	-202.8%
Net Income	-$11M	$12M	-190.2%